DEFINITIVE PROXY STATEMENT

Company

Matinas BioPharma Holdings, Inc.

Filed

September 14, 2017

Period of Report

October 25, 2017

Accession Number

0001626129-17-000527

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →